English EditionEnglish Editionहिन्दी ગુજરાતી मराठी বাংলা ಕನ್ನಡ മലയാളം தமிழ்తెలుగు

| 09 November, 2026, 06:43 AM IST | ePaper |

Exclusives

Covid has given syringe makers an unparalleled opportunity. And a prickly problem

But the big challenge for the manufacturers would be keeping their reputation intact in a country where syringes are often reused. Apart from being illegal, it also becomes a vehicle for infection.

Synopsis
Syringe manufacturers are hopeful of meeting the demand arising out of the upcoming Covid vaccination programme, but a lack of clarity on the type of syringe needed and vaccine delivery dosage has put them in a quandary.

Ever wondered why injections are agonisingly painful sometimes? It depends on the skill of the person administering them, of course. But a badly crafted syringe needle can also cause a mean sting.The sharpness of the needle, the angle at which it is cut and the siliconisation process it has undergone play a major role in ensuring a smooth prick, entry and exit of the thin and sharp piece of steel. A poorly cut or an inadequately siliconised

Shailesh Menon

ET Bureau

13 mins read, Last Updated:

Nov 29, 2020, 10:44:00 AM IST

FONT SIZE
AbcSmall
AbcMedium
AbcLarge
SAVE
PRINT
COMMENT

Uh-oh! This is an exclusive story available for selected readers only.

Worry not. You’re just a step away.

What’s Included with

Prime ETPrime Membership

1Invest Wisely With Smart Market Tools & Investment Ideas

Alpha Trade

Get daily trade ideas from SEBI-registered research analysts.

Investment Ideas

Grow your wealth with stock ideas & sectoral trends.

Stock Reports Plus

All-in-one stock research with Stock Score, peer comparison & key signals.

BigBull Portfolio

Get to know where the market bulls are investing to identify the right stocks.

Stock Analyzer

Check the score based on the company's fundamentals, solvency, growth, risk & ownership to decide the right stocks.

Market Mood

Analyze the market sentiments & identify the trend reversal for strategic decisions.

Stock Talk Live at 9 AM Daily

Ask your stock queries & get assured replies by ET appointed, SEBI registered experts.

2Stay informed anytime, anywhere with ET ePaper

ePaper - Print View

Read the PDF version of ET newspaper. Download & access it offline anytime.

ePaper - Digital View

Read your daily newspaper in Digital View & get it delivered to your inbox everyday.

Wealth Edition

Manage your money efficiently with this weekly money management guide.

3Exclusive Insights That Matter

Uncover the truth with our investigative stories

Make strategic moves using the real-world case studies

Read industry-specific stories to identify emerging trends

Spot opportunities with in-depth insights that matter

Trump temper on H-1B visas is forcing Indians to do these things to stay put in US
What Adani’s US indictment means for India Inc’s overseas fundraising
Why veterans like Reliance, L&T are on acquisition spree? Aswath Damodaran has an answer.
Will China’s dollar bond sale in Saudi Arabia trump the US in financial world?
Huawei launches its own OS to compete with Google and Apple. But can it win beyond China?
The problem with lab grown diamonds
Why a falling rupee is a better option for the economy
A list of top 20 momentum stocks that have delivered massive returns in one year